PGHH_AR_2020

Notes to Financial Statements for the year ended June 30, 2020 Annual Report 2019-20 129 Company Overview Board's Report MD&A CG Report Financial Statement Procter & Gamble Hygiene and Health Care Limited 38 (a) Employ ee Benefits Expense excludes expenses in respect of Managerial personnel of ` 78 Lakhs (Previ ous Year: ` 67 Lakhs) cross charged to Gillette India Limited and Procter & Gamble Home Products Private Limited in terms of the common services agreement (Refer Note 37). 38 (b) Employee Benefits Expense includes expenses in respect of Managerial personnel of ` 171 Lakhs (Previous Year: ` 185 Lakhs) cross charged from Gillette India Limited and Procter & Gamble Home Products Private Limited in terms of the common services agreement (Refer Note 37). 39 Dividend Year ended June 30, 2020 Year ended June 30, 2019 ` in lakhs ` in lakhs Dividend on equity shares paid during the year Final dividend for the FY 2018-19: ` 48 (PY: FY 2017-18: ` 40) per equity share of ` 10 each 15 581 12 984 Dividend distribution tax on final dividend 3 203 2 670 Interim dividend for the FY 2019-20: ` Nil (PY: FY 2018-19: ` 40) per equity share of ` 10 each ---- 12 984 Dividend distribution tax on interim dividend ---- 2 670 Total 18 784 31 308 Proposed Dividend: The Board of Directors at its meeting held on August 25, 2020 have recommended a payment of final dividend of ` 105 per equity share of face value of ` 10 each for the financial year ended June 30, 2020 resulting in a dividend payout of ` 34 084 lakhs. The above is subject to approval at the ensuing Annual General Meeting of the Company and hence is not recognised as a liability. 40 As a result of the nationwide lockdown imposed by the Government of India in view of the Covid-19 pandemic, the operations of the Company were temporarily disrupted at its manufacturing, warehouse and distribution locations from second half of March 2020. The operations have gradually resumed in a phased manner in line with the Government directives issued from time to time. The Company’s Management has evaluated the impact of this pandemic on its business operations and financial position and based on such review, there is no significant impact on the Company’s assets, capital and financial resources, profitability parameters or liquidity positions as at June 30, 2020. The Management does not envisage any impact on the going concern assumption in the foreseeable future. However, the impact assessment of COVID-19 will be a continuing process given the uncertainties associated with its nature and duration. 41 Previous year figures have been regrouped / reclassified wherever necessary to correspond with the current year’s classification / disclosure. 42 Approval of fin ancial statements The financial statements were approved for issue by the board of directors on August 25, 2020. Signatures to Note 1 to 42 For and on behalf of Board of Directors R.A.Shah Chairman Madhusudan Gopalan Managing Director Prashant Bhatnagar Chief Financial Officer Flavia Machado Company Secretary Place: Mumbai Date : August 25, 2020